CELEX: 32019M9277
Language: en
Date: 2019-02-28 00:00:00
Title: Commission Decision of 28/02/2019 declaring a concentration to be compatible with the common market (Case No COMP/M.9277 - Strukturfonden HC15 AB c/o Nalka Invest AB / OneMed AB) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

EUROPEAN COMMISSION
                                                                Brussels, 28.2.2019
                                                                C(2019) 1784 final
                                                                    PUBLIC VERSION
                                                                To the notifying party :
Subject:        Case M.9277 - NALKA INVEST / ONEMED
                Commission decision pursuant to Article 6(1)(b) of Council Regulation (EC)
                                1                                                                             2
                No 139/2004 and Article 57 of the Agreement on the European Economic Area
Dear Sir or Madam,
1.      On 5 February 2019, the European Commission received notification of a proposed
        concentration pursuant to Article 4 of the Merger Regulation by which the undertaking
        Nalka Invest AB (‘Nalka Invest’, Sweden, through its portfolio company Strukturfonden
        HC15 AB (Sweden)), belonging to the Interogo Group, which is ultimately controlled by
        the Interogo Foundation (Liechtenstein), acquires within the meaning of Article 3(1)(b) of
        the Merger Regulation sole control over the whole of OneMed AB (‘OneMed’, Sweden)
        by way of purchase of shares.3
2.      The business activities of the undertakings concerned are:
             for Nalka Invest: a Swedish investment company controlling Strukturfonden HC15
              AB that invests in small and medium-sized companies mainly in the Nordics, aiming
              to invest in different industries and to have a diversified portfolio;
             for Interogo Group: comprises IKEA Holding B.V. (the Netherlands), which has
              several business areas related to the IKEA furniture business, and Interogo Holding
              AG (Switzerland), an investment company which focuses on property investments and
              financial investments;
             for OneMed: provides services, support systems and medical supplies to health care
              providers in the Nordics, Baltics and the Netherlands.
1       OJ L 24, 29.1.2004, p. 1 (the 'Merger Regulation'). With effect from 1 December 2009, the Treaty on the
        Functioning of the European Union ('TFEU') has introduced certain changes, such as the replacement of
        'Community' by 'Union' and 'common market' by 'internal market'. The terminology of the TFEU will be used
        throughout this decision.
2       OJ L 1, 3.1.1994, p. 3 (the 'EEA Agreement').
3       Publication in the Official Journal of the European Union No C 58, 14.02.2019, p. 13.
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË
Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu.
 ---pagebreak--- 3. After examination of the notification, the European Commission has concluded that the
   notified operation falls within the scope of the Merger Regulation and of paragraph 5(b) of
   the Commission Notice on a simplified procedure for treatment of certain concentrations
   under Council Regulation (EC) No 139/2004.4
4. For the reasons set out in the Notice on a simplified procedure, the European Commission
   has decided not to oppose the notified operation and to declare it compatible with the
   internal market and with the EEA Agreement. This decision is adopted in application of
   Article 6(1)(b) of the Merger Regulation and Article 57 of the EEA Agreement.
                                                    For the Commission
                                                    (Signed)
                                                    Johannes LAITENBERGER
                                                    Director-General
4  OJ C 366, 14.12.2013, p. 5.
                                                  2